Holly Springs--Novartis.

Position::Statewide
 
FREE EXCERPT

HOLLY SPRINGS -- Novartis will sell its local manufacturing plant to Australia-based pharmaceutical company CSL as part of a $275 million divestiture of its flu vaccines business. The Basel, Switzerland-based company employs about 550 people at the 475,000-square-foot...

To continue reading

FREE SIGN UP